Evonik
Leading Beyond Chemistry
Company Presentation Q3 2022
Key messages Q3 2022
Solid results in an increasingly challenging market environment
Solid results in an increasingly challenging market environment:
Adj. EBITDA of €615 m in Q3 - supported by a strong Specialty Additives performance (+8% yoy)
Volumes decline, pricing holding up: Double-digit price increases across all growth divisions resulting in ongoing successful pass-on of higher variable costs
Cash generation picking up with FCF of €288 m in Q3;
further significant NWC improvement expected in Q4 to achieve ~30% cash conversion for the full year
Outlook for FY 2022 confirmed: Adj. EBITDA between €2.5 and 2.6 bn
Structural support for 2023: Resilient & regionally balanced portfolio setup, progress in Performance Materials divestment, high visibility on energy costs & gas supply, contingency measure toolbox in implementation
2 November / December 2022 | Evonik Q3 2022 Company Presentation
Table of contents
- Evonik at a glance
- Strategy
- Capital allocation & financial targets
- Financials Q3 2022
3 November / December 2022 | Evonik Q3 2022 Company Presentation
Leading Beyond Chemistry - Our purpose
Evonik on the way to become a best-in-class specialty chemicals company
Video "We are Evonik"
Leading …
… Beyond …
… Chemistry
- Leading market positions in 80% of our business
- Leading key financial indicators
- Connecting skills and perspectives
- Develop solutions together with partners
- Sustainability key driver of growth
- Clear focus on specialty chemicals
- Target 100% specialty portfolio
4 November / December 2022 | Evonik Q3 2022 Company Presentation
Evonik well equipped as "Enabler of Sustainable Change"
Portfolio circled around our four "Sustainability Focus Areas"
ENSURE HEALTH
& WELL-BEING | DRUG DELIVERY SYSTEMS |
Advanced oral & parenteral | |
drug delivery systems | |
(e.g. mRNA LNP) |
SPECIALTY ADDITIVES
for environmentally-friendly solutions, e.g. water-based artificial leather
FIGHT | |
FUTURE MOBILITY | CLIMATE CHANGE |
Lightweight solutions
Solutions for hybrid & full battery cars
ECO-SOLUTIONS
Specialty peroxides solutions
Membranes for gas separation
CIRCULAR ECONOMY
Circular plastic & circular polyurethanes additive solutions
DRIVE
CIRCULARITY
BIO-BASED SOLUTIONS
Bio-based & fully biodegradable surfactants
Natural active cosmetics ingredients
SUSTAINABLE NUTRITION
Omega-3 fatty acids from natural marine algae
Gut health solutions
SAFEGUARD
ECOSYSTEMS
5 November / December 2022 | Evonik Q3 2022 Company Presentation
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Evonik Industries AG published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 November 2022 15:51:03 UTC.